The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive

NCT02677207 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: JNJ-39393406
DRUG: Placebo

Sponsor

Tangent Data

Collaborators

[object Object]